References:
1. Fomin A.B., Pastorino A.C., Kim C.A., Pereira C.A., Carneiro-Sampaio M., and Abe-Jacob C.M., DiGeorge Syndrome: a not so rare disease.Clinics (Sao Paulo), 2010. 65 (9): p. 865-9.10.1590/s1807-59322010000900009
2. Dali-Youcef N. and Andrès E., An update on cobalamin deficiency in adults. Qjm, 2009. 102 (1): p. 17-28.10.1093/qjmed/hcn138
3. Acharya U., Gau J.T., Horvath W., Ventura P., Hsueh C.T., and Carlsen W., Hemolysis and hyperhomocysteinemia caused by cobalamin deficiency: three case reports and review of the literature. J Hematol Oncol, 2008. 1 : p. 26.10.1186/1756-8722-1-26
4. Koury M.J. and Ponka P., New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annu Rev Nutr, 2004.24 : p. 105-31.10.1146/annurev.nutr.24.012003.132306
5. Ventura P., Panini R., Tremosini S., and Salvioli G., A role for homocysteine increase in haemolysis of megaloblastic anaemias due to vitamin B(12) and folate deficiency: results from an in vitro experience. Biochim Biophys Acta, 2004. 1739 (1): p. 33-42.10.1016/j.bbadis.2004.08.005
6. Olinescu R., Kummerow F.A., Handler B., and Fleischer L., The hemolytic activity of homocysteine is increased by the activated polymorphonuclear leukocytes. Biochem Biophys Res Commun, 1996.226 (3): p. 912-6.10.1006/bbrc.1996.1449
7. Pinchas-Hamiel O., Mandel M., Engelberg S., and Passwell J.H.,Immune hemolytic anemia, thrombocytopenia and liver disease in a patient with DiGeorge syndrome. Isr J Med Sci, 1994. 30 (7): p. 530-2
8. Kratz C.P., Niehues T., Lyding S., Heusch A., Janssen G., and Göbel U., Evans syndrome in a patient with chromosome 22q11.2 deletion syndrome: a case report. Pediatr Hematol Oncol, 2003. 20 (2): p. 167-72.10.1080/0880010390158685
9. DePiero A.D., Lourie E.M., Berman B.W., Robin N.H., Zinn A.B., and Hostoffer R.W., Recurrent immune cytopenias in two patients with DiGeorge/velocardiofacial syndrome. J Pediatr, 1997. 131 (3): p. 484-6.10.1016/s0022-3476(97)80085-6
10. Davies J.K., Telfer P., Cavenagh J.D., Foot N., and Neat M.,Autoimmune cytopenias in the 22q11.2 deletion syndrome. Clin Lab Haematol, 2003. 25 (3): p. 195-7.10.1046/j.1365-2257.2003.00508.x
11. Bruno B., Barbier C., Lambilliotte A., Rey C., and Turck D.,Auto-immune pancytopenia in a child with DiGeorge syndrome. Eur J Pediatr, 2002. 161 (7): p. 390-2.10.1007/s00431-002-0976-y
12. Soldatou A., Anastassiou T., Vougiouka O., Goussetis E., and Kossiva L., Transient effect of anti-CD20 therapy in a child with 22q11.2 deletion syndrome and severe steroid refractory cytopenias: a case report. J Pediatr Hematol Oncol, 2013. 35 (4): p. 311-4.10.1097/MPH.0b013e31828be602
13. Sakamoto O., Imaizumi M., Suzuki A., Sato A., Tanaka T., Ogawa E., et al., Refractory autoimmune hemolytic anemia in a patient with chromosome 22q11.2 deletion syndrome. Pediatr Int, 2004.46 (5): p. 612-4.10.1111/j.1442-200x.2004.01940.x
14. Damlaj M. and Séguin C., Refractory autoimmune hemolytic anemia in a patient with DiGeorge syndrome treated successfully with plasma exchange: a case report and review of the literature. Int J Hematol, 2014. 100 (5): p. 494-7.10.1007/s12185-014-1648-1
15. Montin D., Marolda A., Licciardi F., Robasto F., Di Cesare S., Ricotti E., et al., Immunophenotype Anomalies Predict the Development of Autoimmune Cytopenia in 22q11.2 Deletion Syndrome. The Journal of Allergy and Clinical Immunology: In Practice, 2019.7 (7): p. 2369-2376.https://doi.org/10.1016/j.jaip.2019.03.014